期刊文献+

Sequencing the Complete Genome of COVID-19 Virus from Clinical Samples Using the Sanger Method

原文传递
导出
摘要 What is already known on this topic?Coronavirus disease 2019(COVID-19),a disease caused by a novel human coronavirus named the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)or COVID-19 virus,was reported in December 2019.Complete genomes of the COVID-19 virus from clinical samples using next generation sequencing(NGS)have been reported.What is added by this report?Here we provide the technical data for sequencing complete genome of COVID-19 virus from clinical samples using the Sanger method.Two complete COVID-19 virus genome sequences(named WH19004-S and GX0002)were obtained from clinical samples of COVID-19 patients,and two single nucleotide polymorphisms(SNPs)in ORF7a(T/C,nt 27,493)and ORF8(T/C,nt 28,253)of WH19004-S were identified by Sanger sequencing.What are the implications for public health practice?The COVID-19 virus genome sequencing by Sanger method reported here could be used to generate data of high enough quality without requirement for expensive NGS equipment,which support sequencing complete genomes from clinical samples and monitoring of viral genetic variations of COVID-19 infections.
出处 《China CDC weekly》 2020年第25期447-452,共6页 中国疾病预防控制中心周报(英文)
基金 This work was supported by the National Key Research and Development Program of China(2016YFD0500301).
关键词 Sanger CLINICAL ACUTE
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部